Previous Close | 62.27 |
Open | 62.81 |
Bid | 64.10 x 900 |
Ask | 68.00 x 800 |
Day's Range | 62.98 - 64.73 |
52 Week Range | 43.50 - 75.34 |
Volume | |
Avg. Volume | 501,763 |
Market Cap | 3.29B |
Beta (5Y Monthly) | 0.43 |
PE Ratio (TTM) | 76.38 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for HAE
Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2022, which ended April 2, 2022, are available on its Investor Relations website.
Haemonetics Corporation (NYSE: HAE) announced that it will host an Investor Day in Boston on Wednesday, June 29, 2022 beginning at 10:00 AM EDT. Members of Haemonetics' leadership team will share presentations and hold a question-and-answer session on the Company's long-term strategic planning, key business initiatives and financial outlook.
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter fiscal year 2022 financial results at 6:00 am EDT on Tuesday, May 10, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on May 10, 2022.